INDICATION AND IMPORTANT SAFETY INFORMATION FOR NINLARO® (ixazomib)
NINLARO is a prescription medicine used to treat multiple myeloma in combination with the medicines REVLIMID® (lenalidomide) and dexamethasone, in people who have received at least one prior treatment for their multiple myeloma.
We want to make the NINLARO.com experience better for you.
Please tell us about yourself.
I am a:
This program is no longer enrolling new patients.
To explore our patient support services, please visit Takeda Oncology 1Point™.
You are now leaving the NINLARO® (ixazomib) website.
You will be taken to the Medisafe App download page.